HELENE NEYRET KAHN

Docteur,

Ingénieur de recherche

Recherche - Paris

Spécialités / domaines

Biologie,

Epigénétique

Fonctions au sein de l'Institut Curie :

Ingénieur de recherche

Diversité et plasticité des tumeurs de l'enfant (DePiCT)
Unité : Cancer, Hétérogénéité, Instabilité et Plasticité - CHIP (U830)

Publications

2023

Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks

Oncogene

Hélène Neyret-Kahn, Jacqueline Fontugne, Xiang Yu Meng, Clarice S. Groeneveld, Luc Cabel, Tao Ye, Elodie Guyon, Clémentine Krucker, Florent Dufour, Elodie Chapeaublanc, Audrey Rapinat, Daniel Jeffery, Laura Tanguy, Victoria Dixon, Yann Neuzillet, Thierry Lebret, David Gentien, Irwin Davidson, Yves Allory, Isabelle Bernard-Pierrot, François Radvanyi

(2023 mai 05)

2023

Progression‐associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis

The Journal of Pathology

Jacqueline Fontugne, Jennifer Wong, Luc Cabel, Hélène Neyret‐Kahn, Narjesse Karboul, Pascale Maillé, Audrey Rapinat, David Gentien, André Nicolas, Sylvain Baulande, Mathilde Sibony, Isabelle Bernard‐Pierrot, François Radvanyi, Yves Allory

(2023 avr 01)

2023

Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition

International Journal of Biological Sciences

Sara Monteiro-Reis, Vera Miranda-Gonçalves, Catarina Guimarães-Teixeira, Cláudia Martins-Lima, João Lobo, Diana Montezuma, Paula C. Dias, Helene Neyret-Kahn, Isabelle Bernard-Pierrot, Rui Henrique, Carmen Jerónimo

(2023 jan 01)

2021

STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells

Nucleic Acids Research

Laia Richart, Eleonora Lapi, Vera Pancaldi, Mirabai Cuenca-Ardura, Enrique Carrillo-de-Santa Pau, Miguel Madrid-Mencía, Hélène Neyret-Kahn, François Radvanyi, Juan Antonio Rodríguez, Yasmina Cuartero, François Serra, François Le Dily, Alfonso Valencia, Marc A Marti-Renom, Francisco X Real

(2021 nov 08)

2019

TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer

British Journal of Cancer

Florent Dufour, Linda Silina, Hélène Neyret-Kahn, Aura Moreno-Vega, Clémentine Krucker, Narjesse Karboul, Marion Dorland-Galliot, Pascale Maillé, Elodie Chapeaublanc, Yves Allory, Nicolas Stransky, Hélène Haegel, Thierry Menguy, Vanessa Duong, François Radvanyi, Isabelle Bernard-Pierrot

(2019 Mar 01)

2013

Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation

Genome Research

Hélène Neyret-Kahn, Moussa Benhamed, Tao Ye, Stéphanie Le Gras, Jack-Christophe Cossec, Pierre Lapaquette, Oliver Bischof, Maia Ouspenskaia, Mary Dasso, Jacob Seeler, Irwin Davidson, Anne Dejean

(2013 oct 01)

2013

Arkadia, a Novel SUMO-Targeted Ubiquitin Ligase Involved in PML Degradation

Molecular and Cellular Biology

Yigit Erker, Helene Neyret-Kahn, Jacob S. Seeler, Anne Dejean, Azeddine Atfi, Laurence Levy

(2013 juin 01)

2010

Listeria monocytogenes impairs SUMOylation for efficient infection

Nature

David Ribet, Mélanie Hamon, Edith Gouin, Marie-Anne Nahori, Francis Impens, Hélène Neyret-Kahn, Kris Gevaert, Joël Vandekerckhove, Anne Dejean, Pascale Cossart

(2010 avr 01)